| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9be987e54ec2bf57c8e0c2ba86aa413a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-714 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate |
1992-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1993-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-4201196-A1 |
| titleOfInvention |
MULTI-COMPONENT MEDICINE AGAINST POLYNEUROPATHY, ATAXIA, MS, MUSCLE ATROPHY, -HYPOTONIA, -DYSTROPHY |
| abstract |
Polycomponent medicament for treatment of polyneuropathy, ataxia, muscular atrophy, etc. comprises the following combinations: (a) pantothenic acid (or dexpanthenol) and alpha-lipoic acid; (b) vitamin B2 complex and alpha-lipoic acid; (c) panthothenic acid (or dexpanthenol), alpha-lipoic acid and pyridoxine; and (e) B2-complex, alpha-lipoic acid and vitamins B1, B6 and B12. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-4320117-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021255420-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-4439480-C1 |
| priorityDate |
1992-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |